|
|
|
|
| LEADER |
03079nam a2200325 u 4500 |
| 001 |
EB002002077 |
| 003 |
EBX01000000000000001164978 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Trikalinos, Thomas A.
|
| 245 |
0 |
0 |
|a Future research needs for the comparison of percutaneous coronary interventions with bypass graft surgery in nonacute coronary artery disease
|h Elektronische Ressource
|b identification of future research needs from Comparative effectiveness review no. 9
|c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Tufts Evidence-based Practice Center; investigators, Thomas A. Trikalinos ... [et al.]
|
| 260 |
|
|
|a Rockville, MD
|b Agency for Healthcare Research and Quality
|c 2010, [2010]
|
| 300 |
|
|
|a 1 PDF file (various pagings)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Coronary Artery Disease / surgery
|
| 653 |
|
|
|a Angioplasty, Balloon, Coronary
|
| 653 |
|
|
|a Coronary Artery Bypass
|
| 710 |
2 |
|
|a Effective Health Care Program (U.S.)
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 710 |
2 |
|
|a Tufts Evidence-based Practice Center
|
| 740 |
0 |
2 |
|a Comparative effectiveness of percutaneous coronary interventions and coronary artery bypass grafting for coronary artery disease
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Future research needs papers
|
| 500 |
|
|
|a Title from PDF t.p. - "Contract No. 290-2007-10055-I.". - "September 2010.". - Mode of access: Internet
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK51079
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Percutaneous coronary interventions (PCI) with or without stents and coronary artery bypass graft surgery (CABG) are the two broad categories of interventions for mechanical revascularization of atherosclerotic coronary arteries in patients with coronary artery disease (CAD). Generally, both approaches would be clinically relevant for patients with single-vessel disease of the proximal left anterior descending artery, most types of two-vessel disease, as well as for patients with three-vessel disease that is not particularly extensive. Because PCI and CABG differ in their procedural risk and their initial and downstream costs, assessing their comparative effectiveness and safety is of great interest. PCI and CABG have already been compared in several randomized controlled trials (RCTs) and analyses of large clinical registries. The aim of this report is to identify needs for future research in the comparison between PCI and CABG. We use as a basis the 2007 comparative effectiveness review (CER) by the Stanford-University of California at San Francisco Evidence-based Practice Center (Stanford-UCSF EPC) that assessed PCI vs. CABG for coronary artery disease (hereafter we refer to the report as the "Stanford CER" for brevity). The CER summarized evidence published through 2006
|